The tariff classification of Alprazolam Extended Release (ER) Tablets (0.5 mg, 1 mg, 2 mg and 3 mg), Risperidone Tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg), Risperidone Orally Disintegrating Tablets (0.5 mg, 1 mg and 2 mg), and Venlafaxine HCL Tablets (25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg) from India
Reasoning
The tariff classification of Alprazolam Extended Release (ER) Tablets (0.5 mg, 1 mg, 2 mg and 3 mg), Risperidone Tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg), Risperidone Orally Disintegrating Tablets (0.5 mg, 1 mg and 2 mg), and Venlafaxine HCL Tablets (25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg) from India
Cite this ruling
CBP Ruling N023108 (3004909135): The tariff classification of Alprazolam Extended Release (ER) Tablets (0.5 mg, 1 mg, 2 mg and 3 mg), Risperidone Tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg), Risperidone Orally Disintegrating Tablets (0.5 mg, 1 mg and 2 mg), and Venlafaxine HCL Tablets (25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg) from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Thera Flu - flu and cold medicine and Thera Flu - flu, cold & cough medicine from Canada
The tariff classification of Rivaroxaban Tablets in dosage form, from India
The tariff classification of Sacubitril and Valsartan Tablets in dosage form, from India
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
The tariff classification and country of origin of Methylene Blue Injection, USP in dosage form